Charleine, Manomba Boulingui and Bridy, Moutombi Ditombi and Félix, Ngomas Moussadji Jean and Magalie, Essomeyo Mebale and Marion, Ntsame Owono Michelle and Davy, Kombila Ulrich and Philomene, Kouna Ndouongo and Marielle, Bouyou Akotet (2023) Post-COVID-19 Clinical Symptom Frequency and Associated Factors in a Cohort of Patients Discharged from the ICU and Monitored for 12 Months, in Libreville, Gabon. International Journal of TROPICAL DISEASE & Health, 44 (23). pp. 10-20. ISSN 2278-1005
Marielle44232023IJTDH108216.pdf - Published Version
Download (426kB)
Abstract
Aims: This study determined the prevalence and evolution of long COVID symptoms in patients hospitalized for severe COVID-19 at the CHUL intensive care unit in Libreville, Gabon.
Study Design: Prospective, longitudinal, study.
Place and Duration of Study: Infectiology Unit, Centre Hospitalier Universitaire de Libreville Hospitalier Universitaire de LibrevH (CHUL), between January 2021 and January 2022.
Methodology: We included 144 patients (84 men, 60 women; median age 46.4 [16-88] years) hospitalized in the intense care unit for a RT-PCR- confirmed COVID-19 and who have accepted a one-year follow-up. All patients were consulted quarterly for 12 months. During the follow-up, existence, appearance and types of symptoms were sought at 3, 6 and 12-months post-hospitalization.
Results: The prevalence of long COVID-19 was 52.1% (n=75/144). Fatigue (21.3%), cough (20.8%), sleep disorders (16.0%) and anxiety (11.1%) predominated at month-3. The main symptoms reported 6-months after the onset of infection were dyspnea (9.7%; n=14), anxiety (7.6%; n=11), fatigue (6.2%; n=9) and cough (3.5%; n=5). One year after, the persistent symptoms were anxiety (6.5%; n=9), dyspnea (1.4%; n=2). Most participants had only one symptom: 60% at month-3, 79.5% at month-6 and 77.8% at 12-months (p=0.04).
Conclusion: The long COVID is frequent among patients hospitalized for severe form of SARS-COV-2 infection. It is imperative to continue generating information for appropriate prevention and monitoring measures to be adopted in Gabon.
Item Type: | Article |
---|---|
Subjects: | Pustakas > Medical Science |
Depositing User: | Unnamed user with email support@pustakas.com |
Date Deposited: | 11 Dec 2023 05:11 |
Last Modified: | 11 Dec 2023 05:11 |
URI: | http://archive.pcbmb.org/id/eprint/1712 |